Publications

We have conducted robust clinical studies to establish the performance of Phoenixza™.

Encyclopedic Tumor Analysis for Guiding Treatment of Advanced, Broadly Refractory Cancers: Results from The RESILIENT Trial

Author: Nagarkar R
Datar Cancer Genetics
Published Date: Sept 24, 2019

Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers

Author: Crook T
Datar Cancer Genetics
Published Date: Apr 16, 2021

Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers.

Author: Crook T
Datar Cancer Genetics
Published Date: Sept 20, 2021

PDF

Clinical Utility of Circulating Tumor-Associated Cells to Predict and Monitor Chemo-Response in Solid Tumors

Author: Crook T
Datar Cancer Genetics
Published Date: Nov 10, 2020

PDF

Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study

Author: Patil D
Datar Cancer Genetics
Published Date: Dec 23, 2022